Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Cabenuva: The Complete Long-acting Injectable Antiretroviral Regimen


Date: Jul 27, 2021 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Sep 20, 2021 10:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Healthcare Professionals

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Clinical Pharmacy Associates (CPA)

 

 

Registration Closed  

Objectives

  • Describe the history of antiretroviral (ARV) therapy.
  • List the indications and dosing of Cabenuva (Cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension for intramuscular injection, CTG ERIS; RPV ERIS)
  • Recall the Cabenuva clinical trials of safety and efficacy
  • Describe the Cabenuva dispensing process
  • List potential future indications for Cabenuva

Speaker(s)/Author(s)

Hope Coleman, PharmD, BCPS
Associate, Clincial Pharmacy Associates, Inc

Activity Number

0010-9999-21-054-L01-P
Date: 07/27/21
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
Registration Closed